염화제2철이 유도하는 경동맥 손상 렛트 모델에서 상엽 추출물의 혈행개선 효과
Effect of Mori Folium Extract on Improvement of Blood Flow in Ferric Chloride-Induced Carotid Artery Damage Rat Model
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
In a previous study, we have shown that mulberry leaves (Mori Folium) extract MFE) and its compounds have the antioxidant effect in human red blood cells. However, the possible effect of MFE and its compounds on improvement of blood flow were not reported. Therefore, the aim of this study is to investigate the effects of MFE and its compounds on improvement of blood flow in a rat model of topical ferric chloride (FeCl3)-induced carotid artery damage. The FeCl3 treatment seriously damaged the carotid artery: the walls of the artery, blood flow rate, blood vessel diameter, blood vessel area and blood flow amount. However, administration of MFE or its compound has ameliorated the blood flow and suppressed thrombus in blood vessels. Moreover, the concentrations of serum total cholesterol, triglycerides, and LDL cholesterol in the MET and its compound groups were remarkably reduced in comparison to the control group, and HDL cholesterol concentration was higher in the MET and its compound groups than in the control group. These results suggest that MFE and its compounds ameliorate the thrombosis against blood vessel damage.
Abstract
In a previous study, we have shown that mulberry leaves (Mori Folium) extract MFE) and its compounds have the antioxidant effect in human red blood cells. However, the possible effect of MFE and its compounds on improvement of blood flow were not reported. Therefore, the aim of this study is to investigate the effects of MFE and its compounds on improvement of blood flow in a rat model of topical ferric chloride (FeCl3)-induced carotid artery damage. The FeCl3 treatment seriously damaged the carotid artery: the walls of the artery, blood flow rate, blood vessel diameter, blood vessel area and blood flow amount. However, administration of MFE or its compound has ameliorated the blood flow and suppressed thrombus in blood vessels. Moreover, the concentrations of serum total cholesterol, triglycerides, and LDL cholesterol in the MET and its compound groups were remarkably reduced in comparison to the control group, and HDL cholesterol concentration was higher in the MET and its compound groups than in the control group. These results suggest that MFE and its compounds ameliorate the thrombosis against blood vessel damage.
참고문헌 (24)
- Tanaka, H., "Aging, habitual exercise and dynamic arterial compliance", Circulation, 102, pp.1270~1275 (2000)
- Yates, K.F., "Impact of metabolic syndrome on cognition and brain: a selected review of the literature", Arterioscler Thromb Vasc Biol, 32, pp.2060~2067 (2012)
- Fimognari, F. L., "Mechanisms of atherothrombosis in chronic obstructive pulmonary disease", Int J Chron Obstruct Pulmon Dis, 3, pp.89~96 (2008)
- Kleinegris, M. C., "Coagulation and the vessel wall in thrombosis and atherosclerosis", Pol Arch Med Wewn, 122, pp.557~566 (2012)
- Xiromeritis, K., "Acute carotid stent thrombosis after carotid artery stenting", Eur Rev Med Pharmacol Sci, 16, pp.355~362 (2012)
- Marques, M. A., "Acute carotid occlusion and stroke due to antiphospholipid antibody syndrome: case report and literature review", Int Angiol, 29, pp.380~384 (2010)
- Xu, W., "Hematologic diseases: from within the heart", Rev Esp Cardiol, 64, pp.606~613 (2011)
- Ogata, J., "Review: role of cerebral vessels in ischaemic injury of the brain", Neuropathol Appl Neurobiol, 37, pp.40~55 (2011)
- Lockyer, S., "Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis", J Cardiovasc Pharmacol, 33, pp.718~725 (1999)
- Xian, X., "Enhanced atherothrombotic formation after oxidative injury by FeCl3 to the common carotid artery in severe combined hyperlipidemic mice", Biochem Biophys Res Commun, 385, pp.563~569 (2009)
- Warner, T. D., "Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy", Br J Clin Pharmacol, 72, pp.619~633 (2011)
- Williams, M. J., "Aged garlic extract improves endothelial function in men with coronary artery disease", Phytother Res, 19, pp.314~319 (2005)
- Lee, J. J., "Morusinol extracted from Morus alba inhibits arterial thrombosis and modulates platelet activation for the treatment of cardiovascular disease", J Atheroscler Thromb, 19, pp.516~522 (2012)
- Chan, K., "Polyphenol-rich extract from mulberry leaf inhibits vascular smooth muscle cell proliferation involving upregulation of p53 and inhibition of cyclin-dependent kinase", J Agric Food Chem, 58, pp.2536~2542 (2010)
- Song, W. 1., "Phytochemical profiles of different mulberry (Morus sp.) species from China", J Agric Food Chem, 57, pp.9133~9140 (2009)
- Enkhmaa, B., "Mulberry (Morus alba L.) leaves and their major flavonol quercetin 3-(6-malonylglucoside) attenuate atherosclerotic lesion development in LDL receptordeficient mice", J. Nutr, 135, pp.729~734 (2005)
- Asano, N., "Polyhydroxylated alkaloids isolated from mulberry trees (Morus alba L.) and silkworms (Bombyxmori L.)", J Agric Food Chem, 49, pp.4208~4213 (2001)
- Jiwon Choi, "Antioxidant effect of astragalin isolated from the leaves of Morus alba L. against free radical-induced oxidative hemolysis of human red blood cells", Archives of Pharmacal Research, 36(7), pp.912~917 (2013), 대한약학회
- 강현주, "남항(Vitis romaneti) 유래 포도잎 추출물과 Resveratrol의 항산화 및 혈행개선 효과", 한국식품영양과학회지, 42(11), pp.1736~1743 (2013), 한국식품영양과학회
- Frieldwald, W. T., "Estimation of the concentration of low density lipoprotein cholesterol in plasma, wiyh use of the preparative ultracentrifuge", Clin Chem, 18, pp.499~502 (1972)
- Tan, M. H., "Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes", Clin Chem, 50, pp.1184~1188 (2004)
- Grover SA, "Identifying adults at low risk for significant hyperlipidemia: a validated clinical index", J Clin Epidemiol, 52, pp.49~55 (1999)
- Wang, X., "ffects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice", J Thromb Haemost, 3, pp.695~702 (2005)
- Mancini, M., "Ischemic cardiopathy: risk factors and their biological role", Ital Heart J, 2, pp.17~22 (2000)